# FDA Inspection 1190362 - Cagatay Arslan, M.D. - October 28, 2022

Source: https://www.keypedia.com/records/fda_inspections/cagatay-arslan-md/0b55c42a-d2bb-4fc2-8340-ff4fdc47925a
Source feed: FDA_Inspections

> FDA Inspection 1190362 for Cagatay Arslan, M.D. on October 28, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1190362
- Company Name: Cagatay Arslan, M.D.
- Inspection Date: 2022-10-28
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1306730 - 2026-02-19](https://www.keypedia.com/records/fda_inspections/cagatay-arslan-md/0aec2b35-176c-4d09-a361-9eb121c9fc85)

Company: https://www.keypedia.com/companies/cagatay-arslan-md/edd3b71c-8be1-4687-adbf-2f71328a3641

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c